W, L., C, R., E, T., M, K., & P, K. (2026). Seletracetam Revisited: A Missed Opportunity for Effective Epilepsy Therapy. CNS drugs, 40(5), 603. https://doi.org/10.1007/s40263-026-01281-0
Chicago Style (17th ed.) CitationW, Löscher, Rundfeldt C, Trinka E, Koepp M, and Klein P. "Seletracetam Revisited: A Missed Opportunity for Effective Epilepsy Therapy." CNS Drugs 40, no. 5 (2026): 603. https://doi.org/10.1007/s40263-026-01281-0.
MLA (9th ed.) CitationW, Löscher, et al. "Seletracetam Revisited: A Missed Opportunity for Effective Epilepsy Therapy." CNS Drugs, vol. 40, no. 5, 2026, p. 603, https://doi.org/10.1007/s40263-026-01281-0.
Warning: These citations may not always be 100% accurate.
